Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: A longitudinal cohort study

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Nikpour, Mandana ^a,b   Gladman, Dafna D ^a   Ibanez, Dominique ^a   Harvey, Paula J ^c   Urowitz, Murray B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; CHLOROQUINE; CHOLESTEROL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ESTROGEN; GESTAGEN; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; BLOOD PRESSURE VARIABILITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENOPAUSAL SYNDROME; OUTCOME ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; ANALYSIS OF VARIANCE; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DISEASE COURSE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; TIME;

ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CHOLESTEROL; COHORT STUDIES; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 77954045382     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3063     Document Type: Article

References (35)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976, 60:221-225. 10.1016/0002-9343(76)90431-9, 1251849.
2. Nikpour M, Gladman DD, Ibanez D, Bruce IN, Burns RJ, Urowitz MB. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. J Rheumatol 2009, 36:288-294. 10.3899/jrheum.080776, 19208561.
3. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, D'Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997, 145:408-415.
4. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol Suppl 1987, 14(Suppl 13):223-226.
5. Urowitz MB, Ibanez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007, 34:70-75.
6. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senecal JL. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001, 44:2331-2337. 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I, 11665973.
7. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992, 93:513-519. 10.1016/0002-9343(92)90578-Y, 1442853.
8. Bruce IN, Urowitz MB, Gladman DD, Hallett DC. Natural history of hypercholesterolemia in systemic lupus erythematosus. J Rheumatol 1999, 26:2137-2143.
9. Hartley RM, Velez R, Morris RW, D'Souza MF, Heller RF. Confirming the diagnosis of mild hypertension. Br Med J (Clin Res Ed) 1983, 286:287-289. 10.1136/bmj.286.6361.287, 1546485, 6402075.
10. Watson RD, Lumb R, Young MA, Stallard TJ, Davies P, Littler WA. Variation in cuff blood pressure in untreated outpatients with mild hypertension: implications for initiating antihypertensive treatment. J Hypertens 1987, 5:207-211. 10.1097/00004872-198704000-00012, 3611770.
11. Cooper GR, Myers GL, Smith SJ, Schlant RC. Blood lipid measurements: variations and practical utility. JAMA 1992, 267:1652-1660. 10.1001/jama.267.12.1652, 1542176.
12. Lee P, Urowitz MB, Bookman AA, Koehler BE, Smythe HA, Gordon DA, Ogryzlo MA. Systemic lupus erythematosus: a review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 1977, 46:1-32.
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
14. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002, 29:288-291.
15. Craig SR, Amin RV, Russell DW, Paradise NF. Blood cholesterol screening influence of fasting state on cholesterol results and management decisions. J Gen Intern Med 2000, 15:395-399. 10.1046/j.1525-1497.2000.03509.x, 1495473, 10886474.
16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572. 10.1001/jama.289.19.2560, 12748199.
18. Berenson GS, Wattigney WA, Bao W, Srinivasan SR, Radhakrishnamurthy B. Rationale to study the early natural history of heart disease: the Bogalusa Heart Study. Am J Med Sci 1995, 310(suppl 1):S22-28.
19. Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: The Bogalusa Heart Study. Am J Cardiol 2002, 90:3L-7L. 10.1016/S0002-9149(02)02953-3, 12459418.
20. Hegsted DM, Nicolosi RJ. Individual variation in serum cholesterol levels. Proc Natl Acad Sci USA 1987, 84:6259-6261. 10.1073/pnas.84.17.6259, 299050, 3306674.
21. Kreisberg RA, Kasim S. Cholesterol metabolism and aging. Am J Med 1987, 82:54-60. 10.1016/0002-9343(87)90272-5, 3544833.
22. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
23. Borba EF, Bonfa E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997, 6:533-539. 10.1177/096120339700600610, 9256312.
24. Rahman P, Aguero S, Gladman DD, Hallett D, Urowitz MB. Vascular events in hypertensive patients with systemic lupus erythematosus. Lupus 2000, 9:672-675. 10.1191/096120300669204787, 11199921.
25. Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med 1990, 89:322-326. 10.1016/0002-9343(90)90345-E, 2393036.
26. Petri M, Yoo SS. Predictors of glucose intolerance in systemic lupus erythematosus. Arthritis Rheum 1994, 37:S323.
27. Sachet JC, Borba EF, Bonfa E, Vinagre CG, Silva VM, Maranhao RC. Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients. Lupus 2007, 16:273-278. 10.1177/09612033070160040901, 17439934.
28. Binder EF, Williams DB, Schechtman KB, Jeffe DB, Kohrt WM. Effects of hormone replacement therapy on serum lipids in elderly women: a randomized, placebo-controlled trial. Ann Intern Med 2001, 134:754-760.
29. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989, 298:784-788. 10.1136/bmj.298.6676.784, 1836079, 2496857.
30. Narkiewicz K, van de Borne PJ, Hausberg M, Cooley RL, Winniford MD, Davison DE, Somers VK. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998, 98:528-534.
31. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991, 325:1196-1204. 10.1056/NEJM199110243251702, 1922206.
32. Darling GM, Johns JA, McCloud PI, Davis SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med 1997, 337:595-601. 10.1056/NEJM199708283370903, 9271481.
33. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992, 19:403-418.
34. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994, 96:254-259. 10.1016/0002-9343(94)90151-1, 8154514.
35. Karp I, Abrahamowicz M, Fortin PR, Pilote L, Neville C, Pineau CA, Esdaile JM. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?. Arthritis Rheum 2008, 59:169-175. 10.1002/art.23352, 18240259.